BUY Venus Pipes & Tubes Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)24 Aug 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Venus Pipes plans ₹372 crore share sale to 18 investors including Ashish Kacholia
NewsCnbc-Tv18·16 Sept · yesterday
Venus Pipes & Tubes Ltd announced a preferential issue of up to 22,27,544 equity shares at Rs. 1670 per share, aggregating up to Rs. 371.99 crore. An EGM will be held on October 8, 2026, to seek share
BSE · Company Update·16 Sept · yesterday
Venus Pipes & Tubes Ltd approved a preferential issue of up to 22,27,544 equity shares at Rs. 1670 per share, aggregating up to Rs. 371.99 crore. An EGM will be held on Oct 8, 2026, to seek shareholde
BSE · Board Meeting·16 Sept · yesterday
Venus Pipes & Tubes Limited's Board approved a preferential issue of up to 22,27,544 equity shares at Rs. 1670 per share, aggregating up to Rs. 371.99 crore. An EGM will be held on Oct 8, 2026, to see
NSE · Outcome of Board Meeting·16 Sept · yesterday
Venus Pipes & Tubes posts record ₹320.5 crore revenue in Q1FY27
NewsGoogle News·30 Aug · 3w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Venus Pipes & Tubes
- BUY — Nuvama Wealth1 Oct 2026 · ~1 year · target ₹3,000 · Active
- BUY — Sahi Research31 Aug 2026 · ~2 weeks · target ₹1,700 · SL hit
- BUY — IDBI Capital10 Aug 2026 · ~3 months · target ₹1,955 · Target hit
- BUY — Anand Rathi13 Mar 2025 · ~1 year · target ₹1,700 · Expired
More from ICICI Securities
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Tatva Chintan Pharma Chem20 Oct 2026 · ~1 year · target ₹2,385 · Active
- BUY Crompton Greaves Consumer Electricals19 Oct 2026 · ~1 year · target ₹275 · Active

